Jpmorgan Chase & Co »

Orchard Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Orchard Therapeutics shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Orchard Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Orchard Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Orchard Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $447k 27k 16.45
2023-09-30 $166k 21k 7.76
2023-06-30 $173k 33k 5.19
2023-03-31 $260k 48k 5.39